These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 24651587)

  • 1. Comparative effectiveness and tolerance of treatments for Helicobacter pylori: systematic review and network meta-analysis.
    Li BZ; Threapleton DE; Wang JY; Xu JM; Yuan JQ; Zhang C; Li P; Ye QL; Guo B; Mao C; Ye DQ
    BMJ; 2015 Aug; 351():h4052. PubMed ID: 26290044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Empiric use of standard triple therapy in
    Malfertheiner P; Megraud F; Rokkas T; Gisbert JP
    Gut; 2024 Mar; 73(4):708-709. PubMed ID: 36878681
    [No Abstract]   [Full Text] [Related]  

  • 3. Unlocking the path to efficient
    Borody TJ; Ng J; Dolai S
    Saudi J Gastroenterol; 2023; 29(6):323-325. PubMed ID: 37706422
    [No Abstract]   [Full Text] [Related]  

  • 4. Clarithromycin-containing triple therapy for
    Sjomina O; Vangravs R; Ļeonova E; Poļaka I; Pūpola D; Čivkulis K; Jeniceka A; Paršutins S; Stonāns I; Park JY; Engstrand L; Leja M
    Gut; 2024 Jun; 73(7):1214-1215. PubMed ID: 37364984
    [No Abstract]   [Full Text] [Related]  

  • 5. Concentrating on the Long Topic of Empirical or Not Conventional Helicobacter pylori Eradication Regimens.
    Kountouras J
    Clin Gastroenterol Hepatol; 2023 Aug; 21(9):2433-2434. PubMed ID: 36343844
    [No Abstract]   [Full Text] [Related]  

  • 6. Response to: a true point-of-care molecular testing method for tailored therapy for
    Graham DY; Rokkas T
    Expert Rev Gastroenterol Hepatol; 2023 Mar; 17(3):311. PubMed ID: 36765449
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacodynamic effects of nitroimidazoles alone and in combination with clarithromycin on Helicobacter pylori.
    Svensson M; Nilsson LE; Ström M; Nilsson M; Sörberg M
    Antimicrob Agents Chemother; 2002 Jul; 46(7):2244-8. PubMed ID: 12069981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton Pump Inhibitors: Adversaries In Our Fight Against Antibiotic Resistance?
    Umar S; Ejaz Z; Masood F
    J Pak Med Assoc; 2023 Nov; 73(11):2326. PubMed ID: 38013579
    [No Abstract]   [Full Text] [Related]  

  • 9. Antibiotic treatment for Helicobacter pylori: Is the end coming?
    Kim SY; Choi DJ; Chung JW
    World J Gastrointest Pharmacol Ther; 2015 Nov; 6(4):183-98. PubMed ID: 26558152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [First line eradication treatment of Helicobacter pylori in 2019].
    Gressot P; Frossard JL; Grosgurin O; Marti C
    Rev Med Suisse; 2019 Oct; 15(667):1854-1858. PubMed ID: 31617972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic review and meta-analysis: proton pump inhibitor vs. ranitidine bismuth citrate plus two antibiotics in Helicobacter pylori eradication.
    Gisbert JP; Gonzalez L; Calvet X
    Helicobacter; 2005 Jun; 10(3):157-71. PubMed ID: 15904473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New therapeutic strategies against Helicobacter pylori].
    Kang BK; Park SM; Kim BW
    Korean J Gastroenterol; 2014 Mar; 63(3):146-50. PubMed ID: 24651587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Changes in the eradication rate of conventional triple therapy for Helicobacter pylori infection in Korea].
    Heo J; Jeon SW
    Korean J Gastroenterol; 2014 Mar; 63(3):141-5. PubMed ID: 24651586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concomitant therapy achieved the best eradication rate for Helicobacter pylori among various treatment strategies.
    Lee HJ; Kim JI; Lee JS; Jun EJ; Oh JH; Cheung DY; Chung WC; Kim BW; Kim SS
    World J Gastroenterol; 2015 Jan; 21(1):351-9. PubMed ID: 25574111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonbismuth quadruple (concomitant) therapy: empirical and tailored efficacy versus standard triple therapy for clarithromycin-susceptible Helicobacter pylori and versus sequential therapy for clarithromycin-resistant strains.
    Molina-Infante J; Pazos-Pacheco C; Vinagre-Rodriguez G; Perez-Gallardo B; Dueñas-Sadornil C; Hernandez-Alonso M; Gonzalez-Garcia G; Mateos-Rodriguez JM; Fernandez-Bermejo M; Gisbert JP
    Helicobacter; 2012 Aug; 17(4):269-76. PubMed ID: 22759326
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.